2nd Quarter - Amendment

WILLIAMS AND JENSEN, PLLC for ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)

Firm
Client
Income
$80,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 18, 2014 $80,000 Replaced
2nd Quarter - Amendment (this page) Jul 18, 2014 $80,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of Patient Protection and Affordable Care Act. Drug safety and drug counterfeiting.Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; drug shortages.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN —
GEORGE OLSEN —
ANTHONY J RODA —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE

Taxation/Internal Revenue Code TAX

Tax issues affecting the pharmaceutical industry, tax reform issues.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
TESS ILLOS —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); State, Dept of (DOS)

Medicare/Medicaid MMM

Medicare prescription drug benefit. Drug rebates for Medicare Part D. Part D benefit structure. Indpendent Payment Advisory Board (IPAB).

LobbyistCovered position, as disclosed
JACK STEVEN HART —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; State, Dept of (DOS)

Veterans VET

Pharmaceutical sourcing from non-Trade Agreement Act countries.

LobbyistCovered position, as disclosed
MATTHEW B HOEKSTRA —
GEORGE OLSEN —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS)

Foreign Relations FOR

Market access issues.

LobbyistCovered position, as disclosed
ERIC STEWART New COS and Deputy Asst. Sec., Dept. of Commerce

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTRAZENECA AB Sweden Sweden 90.3% —
ASTRAZENECA TREASURY LIMITED United Kingdom United Kingdom 100.0% —
ASTRAZENECA PLC United Kingdom United Kingdom 100.0% —
ASTRAZENECA UK LIMITED United Kingdom United Kingdom 100.0% —
ASTRAZENECA INTERMEDIATE HOLDINGS LTD. United Kingdom United Kingdom 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.